Skip Navigation LinksHome > August 1, 2013 - Volume 63 - Issue 4 > HIV-1–Infected Individuals in Antiretroviral Therapy React S...
JAIDS Journal of Acquired Immune Deficiency Syndromes:
doi: 10.1097/QAI.0b013e31828fa22b
Basic and Translational Science

HIV-1–Infected Individuals in Antiretroviral Therapy React Specifically With Polyfunctional T-Cell Responses to Gag p24

Brandt, Lea PhD*; Benfield, Thomas MD, DMSc†,‡; Kronborg, Gitte MD; Gerstoft, Jan MD§; Fomsgaard, Anders MD, DMSc*,‖; Karlsson, Ingrid PhD*

Supplemental Author Material
Collapse Box


Background: Still no effective HIV-1 prophylactic or therapeutic vaccines are available. However, as the proportion of HIV-1–infected individuals on antiretroviral treatment is increasing, knowledge about the residual immune response is important for the possible development of an HIV-1 vaccine.

Methods: In this study, the magnitude, breadth, and quality of the HIV-1–specific T-cell response in HIV-1–infected viremic individuals (n = 19) and individuals on highly active antiretroviral treatment (HAART) (n = 14) using multicolor flow cytometry were determined.

Results: We found that magnitude and breadth of the CD8 T-cell response were significantly higher in viremic individuals than individuals on HAART (P < 0.0001 and P < 0.0001, respectively) and that the functionality of the overall HIV-1–specific response was significantly different in individuals on HAART and viremic individuals (P = 0.0020). In individuals on HAART, the remaining responses were primarily detected upon stimulation with overlapping peptides from Gag p24, integrase, and Nef. The Gag p24 response was more polyfunctional than corresponding responses observed in viremic individuals.

Conclusions: Identification of highly immunogenic regions also recognized by individuals on HAART may be important for HIV-1 vaccine development. Irrespective of HLA haplotype, specific regions within the HIV-1 genome that is targeted more frequently in individuals on HAART have been identified. However, further studies are required to establish if these particular regions could be interesting for a future vaccine that might limit the time and opportunity for escape mutations.

© 2013 by Lippincott Williams & Wilkins


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.